Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionNvwm, Llc
Latest Disclosed Ownership6 shares
Latest Disclosed Value $ 2,679
Nvwm, Llc ownership in VRTX / Vertex Pharmaceuticals Incorporated

On April 27, 2026 - Nvwm, Llc filed a 13F-HR form disclosing ownership of 6 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $2,679 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 6 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $2,570 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 6 0 0.00 3 0.00 0.0003
2026-01-20 2025-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 6 -56 -90.32 3 -91.67 0.0006
2025-10-16 2025-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 62 -2,305 -97.38 24 -97.72 0.0055
2025-08-06 2025-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,367 -16 -0.67 1,054 -8.83 0.2544
2025-05-07 2025-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,383 -1 -0.04 1,155 20.31 0.3069
2025-01-27 2024-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,384 -23 -0.96 960 -14.21 0.2422
2024-10-29 2024-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,407 -10 -0.41 1,119 -1.15 0.2849
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,417 -8 -0.33 1,133 11.75 0.3017
2024-05-07 2024-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,425 47 1.98 1,014 4.76 0.2783
2024-02-08 2023-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,378 -72 -2.94 968 13.63 0.2900
2023-10-30 2023-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,450 9 0.37 852 -0.93 0.2784
2023-08-08 2023-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,441 52 2.18 859 14.23 0.2793
2023-05-11 2023-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,389 250 11.69 753 21.88 0.2522
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,139 2,073 3,140.91 618 3,147.37 0.2243
2022-11-15 2022-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 66 66 19 0.0075
2022-02-08 2021-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 0 -25 -100.00 0 -100.00
2021-11-03 2021-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 25 25 5 0.0018
2021-05-11 2021-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 0 -25 -100.00 0 -100.00
2021-02-09 2020-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 25 -4,202 -99.41 5 -99.57 0.0021
2020-12-10 2020-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 4,227 136 3.32 1,151 -3.03 0.5404
2020-08-11 2020-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 4,091 12 0.29 1,187 22.25 0.6392
2020-05-08 2020-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 4,079 481 13.37 971 23.22 0.6747
2020-02-07 2019-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 3,598 -622 -14.74 788 10.21 0.4720
2019-11-08 2019-09-30 13F/A-1 VERTEX PHARMACEUTICALS INC COM COM 92532F100 4,220 997 30.93 715 20.98 0.4393
2019-10-29 2019-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 4,220 997 715 0.4380
2019-08-07 2019-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 3,223 146 4.74 591 4.42 0.3565
2019-05-10 2019-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 3,077 100 3.36 566 14.81 0.3750
2019-01-29 2018-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,977 0 0.00 493 -14.11 0.3693
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,977 2,758 1,259.36 574 1,451.35 0.3629
2018-08-01 2018-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 219 0 0.00 37 8.82 0.0257
2018-05-17 2018-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 219 77 54.23 34 61.90 0.0248
2018-03-15 2017-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 142 142 21 0.0160
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.